This is the Scientific Surgery Archive, which contains all randomized clinical trials in surgery that have been identified by searching the top 50 English language medical journal issues since January 1998. Compiled by Jonothan J. Earnshaw, former Editor-in-Chief, BJS
Single‐centre experience of laparoscopic pancreatic surgery. BJS 2010; 97: 902-909.
Published: 21st April 2010
Authors: B. I. Røsok, I. P. Marangos, A. M. Kazaryan, A. R. Rosseland, T. Buanes, Ø. Mathisen et al.
Background
Laparoscopic resection is regarded as safe and feasible in selected patients with benign pancreatic tumours. Few data exist on laparoscopic surgery for malignant lesions and larger neoplasms in unselected patients.
Method
The study included all patients admitted to Oslo University Hospital, Rikshospitalet, from March 1997 to March 2009 for surgery of lesions in the body and tail of the pancreas, and selected patients with lesions in the pancreatic head, who underwent surgery by a laparoscopic approach with curative intent.
Results
A total of 166 patients had 170 operations, including 138 pancreatic resections, 18 explorations, nine resections of peripancreatic tissue and five other therapeutic procedures. Four patients had repeat procedures. There were 53 endocrine tumours (31·0 per cent), 28 pancreatic carcinomas (16·4 per cent), five cases of metastases (2·9 per cent), 48 cystic tumours (28·1 per cent) and 37 other lesions (21·6 per cent). The total morbidity rate was 16·5 per cent. Fistula was the most common complication (10·0 per cent). Three patients needed reoperation for complications. There were three hospital deaths (1·8 per cent). Median hospital stay following surgery was 4 days.
Conclusion
Laparoscopic resection of lesions in the body and tail of the pancreas in an unselected patient series was safe and feasible, and should be the method of choice for this patient group in specialized centres. Copyright © 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
Full text